KineMed, Inc. to Present Neuroinflammation Data from Plexxikon Partner Study at 2013 Society For Neuroscience Conference

KineMed, Inc. (www.kinemed.com) today announced that Dr. Mahalakshmi Shankaran, Director of Muscle and Neurobiology at KineMed, Inc., will present preclinical data demonstrating the use of KineMed’s biomarker platform technology to measure the effects of Plexxikon’s FMS kinase inhibitor, PLX5622, on neuroinflammation at the 43rd annual meeting of the Society for Neuroscience being held in San Diego, California, November 9-13, 2013.

Help employers find you! Check out all the jobs and post your resume.